<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Secondary porphyrinopathias were investigated in hereditary <z:hpo ids='HP_0002904'>hyperbilirubinemias</z:hpo> of the types <z:e sem="disease" ids="C0022350" disease_type="Disease or Syndrome" abbrv="">Dubin-Johnson syndrome</z:e> (DJS), <z:e sem="disease" ids="C0220991" disease_type="Disease or Syndrome" abbrv="">Rotor's syndrome</z:e> (RS), <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> (GS) and compared with the findings in alcohol-induced <z:hpo ids='HP_0001396'>cholestasis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The determination of urinary coproporphyrin excretion including its isomer I and III relation allows to diagnose and differentiate DJS from the other two forms of hereditary <z:hpo ids='HP_0002904'>hyperbilirubinemias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>An isomer I proportion of &gt; 80% (<z:mpath ids='MPATH_458'>normal</z:mpath> &lt; 32%) in association with a <z:mpath ids='MPATH_458'>normal</z:mpath> coproporphyrin excretion is pathognomonic for DJS </plain></SENT>
<SENT sid="3" pm="."><plain>An increased <z:e sem="disease" ids="C1263734" disease_type="Disease or Syndrome" abbrv="">coproporphyrinuria</z:e> with about 70% isomer I is found in RS; a <z:mpath ids='MPATH_458'>normal</z:mpath> urinary coproporphyrin excretion combined with an isomer I increase of about 50-70% indicates the frequent GS </plain></SENT>
<SENT sid="4" pm="."><plain>Alcohol-related <z:hpo ids='HP_0001396'>cholestasis</z:hpo> reveals a distinct pathologic <z:e sem="disease" ids="C1263734" disease_type="Disease or Syndrome" abbrv="">coproporphyrinuria</z:e> and elevated isomer I proportions between 37-67% </plain></SENT>
<SENT sid="5" pm="."><plain>Due to the overlapping of isomer alterations in DJS-gene carriers, patients with GS and patients with exogenous toxically-induced <z:hpo ids='HP_0001396'>cholestasis</z:hpo>, additional diagnostic criteria are required to clarify the porphyrinopathia in its clinical context </plain></SENT>
</text></document>